Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.

NN Mehta, R Ravikumar, CA Coldham, John Buckels, Stefan Hubscher, Simon Bramhall, SJ Wigmore, AD Mayer, Darius Mirza

Research output: Contribution to journalArticle

72 Citations (Scopus)


AIM: To compare the effects of preoperative chemotherapy on liver parenchyma morphology, as well as morbidity and mortality after liver resection for colorectal liver metastases. METHODS: Prospectively collected data on 173 patients undergoing liver resection for CLM between 1/2003 and 9/2005 was analysed in three groups: A: preoperative oxaliplatin (Ox, n=70); B: other chemotherapeutic agents (OC, n=60); and C: surgery alone without chemotherapy (SA, n=43). Blood transfusion, hospital stay, operative procedure, peak postoperative bilirubin levels, complications and histopathology of the resected liver were compared. RESULTS: Intra-operative blood transfusion requirement (34%) and biliary complications (16%) was higher in patients receiving oxaliplatin-based chemotherapy (p=0.01 and p=0.06, respectively). Oxaliplatin-based chemotherapy was also associated with sinusoidal dilatation of mild grade in 52.8% vs. 26.6% and 23.3% patients (p=0.007 and p=0.004) in other groups, respectively. Steatosis was similarly distributed across the study group. Postoperative mortality was 2, 1 and 4 patients, respectively (p=ns). CONCLUSION: Oxaliplatin-based preoperative chemotherapy is associated with vascular alterations in the liver parenchyma without significantly increasing the risk of steatosis, or postoperative morbidity and mortality.
Original languageEnglish
Pages (from-to)782-6
Number of pages5
JournalEuropean Journal of Surgical Oncology (EJSO)
Issue number7
Publication statusPublished - 1 Jul 2008


Dive into the research topics of 'Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.'. Together they form a unique fingerprint.

Cite this